Health Research, Inc.   Report issue

Foundation Phase 2 Phase 4
Founded: Menands NY United States (1953)

Organization Overview

First Clinical Trial
2005
NCT00668941
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

denosumab (prolia) (1 trial)

teriparatide (3 trials)

Drugs in Phase 2 Trials (3)

alendronic acid (fosamax) (1 trial)

calcium (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5